title: Does robotic prostatectomy meet its promise in the management of prostate cancer?
abstract: Following Walsh's advances in pelvic anatomy and surgical technique to minimize intraoperative peri-prostatic trauma more than 30 years ago, open retropubic radical prostatectomy (RRP) evolved to become the gold standard treatment of localized prostate cancer, with excellent long-term survival outcomes [1•]. However, RRP is performed with great heterogeneity, even among high volume surgeons, and subtle differences in surgical technique result in clinically significant differences in recovery of urinary and sexual function. Since the initial description of robotic-assisted radical prostatectomy (RARP) in 2000 [2], and U.S. Food and Drug Administration approval shortly thereafter, RARP has been rapidly adopted and has overtaken RRP as the most popular surgical approach in the management of prostate cancer in the United States [3]. However, the surgical management of prostate cancer remains controversial. This is confounded by the idolatry of new technologies and aggressive marketing versus conservatism in embracing tradition. Herein, we review the literature to compare RRP to RARP in terms of perioperative, oncologic, and quality-of-life outcomes as well as healthcare costs. This is a particularly relevant, given the absence of randomized trials and long-term (more than 10-year) follow-up for RARP biochemical recurrence-free survival.
authors.affiliation: Institute of Urologic Oncology, Department of Urology, David Geffen School of Medicine, University of California Los Angeles, 924 Westwood Blvd, Suite 1000, Los Angeles, CA 90024, USA.
authors.forename: Kuo-How
authors.initials: KH
authors.lastname: Huang
authors.forename: Stacey C
authors.initials: SC
authors.lastname: Carter
authors.forename: Jim C
authors.initials: JC
authors.lastname: Hu
mesh_terms: D018572:Disease-Free Survival; D007172:Erectile Dysfunction / Q000209:etiology; D017048:Health Care Costs; D006801:Humans; D008297:Male; D011468:Prostatectomy / Q000009:adverse effects / Q000191:economics / Q000379:methods*; D011471:Prostatic Neoplasms / Q000601:surgery*; D011788:Quality of Life; D012371:Robotics / Q000191:economics / Q000379:methods*; D016896:Treatment Outcome; D014549:Urinary Incontinence / Q000209:etiology
references.citation: J Urol. 2010 May;183(5):1822-8
references.pmid: 20303100
references.citation: Urology. 2010 May;75(5):1083-9
references.pmid: 20110114
references.citation: BJU Int. 2011 Jan;107(1):100-4
references.pmid: 20633003
references.citation: Urology. 2008 May;71(5):906-10
references.pmid: 18372016
references.citation: J Clin Oncol. 2008 May 10;26(14):2278-84
references.pmid: 18467718
references.citation: Eur Urol. 2012 Aug;62(2):261-72
references.pmid: 22575909
references.citation: Eur Urol. 2009 May;55(5):1037-63
references.pmid: 19185977
references.citation: JAMA. 2011 Dec 28;306(24):2721-2
references.pmid: 22203543
references.citation: Eur Urol. 2012 Nov;62(5):806-13
references.pmid: 22705382
references.citation: Eur Urol. 2007 Mar;51(3):684-8; discussion 689
references.pmid: 16835007
references.citation: Rev Urol. 2001 Summer;3(3):113-9
references.pmid: 16985703
references.citation: Eur Urol. 2012 Apr;61(4):803-9
references.pmid: 22209053
references.citation: N Engl J Med. 2009 Mar 26;360(13):1310-9
references.pmid: 19297565
references.citation: JSLS. 2010 Jan-Mar;14(1):1-5
references.pmid: 20529522
references.citation: Eur Urol. 2011 Jan;59(1):72-80
references.pmid: 20801579
references.citation: Eur Urol. 2010 Dec;58(6):838-46
references.pmid: 20869162
references.citation: J Natl Cancer Inst. 2010 Jul 7;102(13):950-8
references.pmid: 20562373
references.citation: N Engl J Med. 2012 Jul 19;367(3):270-1
references.pmid: 22808963
references.citation: J Urol. 2010 May;183(5):1803-7
references.pmid: 20299041
references.citation: J Clin Oncol. 2004 Jun 1;22(11):2141-9
references.pmid: 15169800
references.citation: J Urol. 1991 Mar;145(3):512-4; discussion 514-5
references.pmid: 1997701
references.citation: J Urol. 2004 Oct;172(4 Pt 1):1431-5
references.pmid: 15371862
references.citation: J Urol. 1998 Dec;160(6 Pt 2):2418-24
references.pmid: 9817395
references.citation: N Engl J Med. 2009 Mar 26;360(13):1320-8
references.pmid: 19297566
references.citation: J Urol. 2010 Apr;183(4):1366-72
references.pmid: 20188381
references.citation: J Urol. 2005 Sep;174(3):915-8
references.pmid: 16093987
references.citation: N Engl J Med. 2012 Jul 19;367(3):203-13
references.pmid: 22808955
references.citation: J Clin Oncol. 2011 Feb 1;29(4):355-61
references.pmid: 21041707
references.citation: Eur Urol. 2010 Mar;57(3):453-8
references.pmid: 19931979
references.citation: J Urol. 2007 Sep;178(3 Pt 1):854-8; discussion 859
references.pmid: 17631338
references.citation: J Urol. 2010 Mar;183(3):990-6
references.pmid: 20083261
references.citation: J Urol. 2012 Apr;187(4):1392-8
references.pmid: 22341274
references.citation: BJU Int. 2009 Feb;103(4):448-53
references.pmid: 18778350
references.citation: Eur Urol. 2014 Feb;65(2):316-24
references.pmid: 22981673
references.citation: Surg Oncol. 2009 Sep;18(3):242-6
references.pmid: 19560913
references.citation: BJU Int. 2003 Aug;92(3):205-10
references.pmid: 12887468
references.citation: N Engl J Med. 2008 Mar 20;358(12):1250-61
references.pmid: 18354103
references.citation: Eur Urol. 2011 Sep;60(3):413-9
references.pmid: 21612859
references.citation: J Endourol. 2008 Oct;22(10):2299-305
references.pmid: 18837657
references.citation: Scand J Urol Nephrol. 2009;43(5):350-6
references.pmid: 19921978
references.citation: BJU Int. 2009 Oct;104(7):991-5
references.pmid: 19426191
references.citation: Urology. 2006 Feb;67(2):360-3
references.pmid: 16461085
references.citation: JAMA. 2009 Oct 14;302(14):1557-64
references.pmid: 19826025
references.citation: Eur Urol. 2011 Feb;59(2):235-43
references.pmid: 20863611
references.citation: J Urol. 2007 Mar;177(3):929-31
references.pmid: 17296378
references.citation: Urology. 2010 May;75(5):1092-7
references.pmid: 20022085
references.citation: Eur Urol. 2012 Sep;62(3):418-30
references.pmid: 22749850
references.citation: Scand J Urol Nephrol. 2009;43(4):259-64
references.pmid: 19353381
references.citation: Eur Urol. 2011 Jan;59(1):1-6
references.pmid: 21035248
references.citation: Curr Opin Urol. 2011 May;21(3):200-5
references.pmid: 21427586
references.citation: Urology. 2009 Feb;73(2):316-22
references.pmid: 18952266
references.citation: Int Braz J Urol. 2010 May-Jun;36(3):259-72
references.pmid: 20602818
references.citation: Eur Urol. 2012 Mar;61(3):541-8
references.pmid: 22153926
references.citation: Urol Oncol. 2013 Oct;31(7):1043-8
references.pmid: 22222059
references.citation: Med Care. 1998 Jul;36(7):1002-12
references.pmid: 9674618
references.citation: BJU Int. 2010 Oct;106(7):1036-40
references.pmid: 20151960
references.citation: Prog Urol. 2000 Sep;10(4):520-3
references.pmid: 11064890
references.citation: N Engl J Med. 2011 May 5;364(18):1708-17
references.pmid: 21542742
references.citation: Urology. 2000 Dec 20;56(6):899-905
references.pmid: 11113727
references.citation: Eur Urol. 2012 Apr;61(4):679-85
references.pmid: 22206800
references.citation: J Urol. 2001 Nov;166(5):1729-33
references.pmid: 11586211
references.citation: Eur Urol. 2010 Jun;57(6):945-52
references.pmid: 20181424
references.citation: Rev Urol. 2010 Winter;12(1):35-43
references.pmid: 20428292
references.citation: N Engl J Med. 2012 Mar 15;366(11):981-90
references.pmid: 22417251
references.citation: Clin Ther. 2001 Oct;23(10):1707-19
references.pmid: 11726005
references.citation: BJU Int. 2009 Nov;104(10):1496-500
references.pmid: 19388991
references.citation: J Urol. 2005 Dec;174(6):2323-9
references.pmid: 16280833
references.citation: JAMA. 1999 May 5;281(17):1591-7
references.pmid: 10235151
references.citation: Urol Oncol. 2012 Sep;30(5):569-76
references.pmid: 20822929
references.citation: Eur Urol. 2012 Sep;62(3):405-17
references.pmid: 22749852
references.citation: Eur Urol. 2012 Sep;62(3):431-52
references.pmid: 22749853
references.citation: Scand J Urol Nephrol. 2006;40(6):453-8
references.pmid: 17130096
references.citation: Eur Urol. 2009 Dec;56(6):972-80
references.pmid: 19781848
references.citation: J Urol. 2002 Sep;168(3):945-9
references.pmid: 12187196
references.citation: BJU Int. 2010 Dec;106(11):1734-8
references.pmid: 20438567
references.citation: Eur Urol. 2011 Sep;60(3):536-47
references.pmid: 21620561
references.citation: JAMA. 1995 Feb 15;273(7):548-52
references.pmid: 7530782
references.citation: J Urol. 1995 Jun;153(6):1870-2
references.pmid: 7752336
references.citation: J Endourol. 2010 Dec;24(12):2003-15
references.pmid: 20942686
references.citation: J Urol. 1999 Aug;162(2):433-8
references.pmid: 10411052
references.citation: J Urol. 2007 Dec;178(6):2385-9; discussion 2389-90
references.pmid: 17936849
references.citation: Eur Urol. 2012 Sep;62(3):382-404
references.pmid: 22749851
references.citation: BJU Int. 2009 Aug;104(4):534-9
references.pmid: 19281468
references.citation: Urology. 2009 Sep;74(3):619-23
references.pmid: 19592075
references.citation: Urology. 2003 Oct;62(4):702-6
references.pmid: 14550447
references.citation: J Sex Med. 2010 Feb;7(2 Pt 1):839-45
references.pmid: 19912486
references.citation: Eur Urol. 2012 Jul;62(1):1-15
references.pmid: 22405509